Hypertriglyceridemia omega-3 fatty acids

Revision as of 15:10, 15 September 2013 by Rim Halaby (talk | contribs)
Jump to navigation Jump to search

Triglyceride Microchapters

Home

Patient information

Overview

Historical Perspective

Classification

Biochemistry

Physiology

Clinical Correlation

Triglyceride Laboratory Test

High Triglyceride

Epidemiology and Demographics
Pathophysiology
Causes
Prognosis and Complications
History and Symptoms
Physical Examination

Low Triglyceride

Epidemiology and Demographics
Pathophysiology
Causes
Prognosis and Complications

Treatment

Lifestyle modification

Medical Therapy

Primary Prevention

Secondary Prevention

Landmark Trials

Future or Investigational Therapies

Case Studies

Case #1

Hypertriglyceridemia omega-3 fatty acids On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hypertriglyceridemia omega-3 fatty acids

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hypertriglyceridemia omega-3 fatty acids

CDC on Hypertriglyceridemia omega-3 fatty acids

Hypertriglyceridemia omega-3 fatty acids in the news

Blogs on Hypertriglyceridemia omega-3 fatty acids

Directions to Hospitals Treating Triglyceride

Risk calculators and risk factors for Hypertriglyceridemia omega-3 fatty acids

For full Omega-3 fatty acid drug info click here

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Priyamvada Singh, M.B.B.S. [2]

Overview

Treatment of hypertriglyceridemia is by restriction of carbohydrates and fat in the diet, as well as with niacin, fibrates and statins (three classes of drugs). Increased fish oil intake may substantially lower an individual's triglycerides.[1][2][3].

Trial Supportive Data

Study name Source & year Study question Study Design Study Population Time period Intervention Results Conclusions
Effect of combination of Omega-3 fatty acid and Simvastatin on hypertriglyceridemia [4] Heart, 2001 To access the safety and efficacy of Omega-3 fatty acid and Simvastatin on hypertriglyceridemia Double blinded randomized controlled trial 59 patients with CHD, on simvastatin 10-40 mg/d, with serum triglycerides > 2.3 mmol/l 1 year Omacor (84% omega-3 fatty acid) 2 g BD or placebo
  • Decrease in serum triglycerides by 20-30% (p<0.005)
  • Decrease in very low-density lipoprotein (VLDL) cholesterol by 30-40% (p<0.005)


{{#ev:youtube|9l94Nm241GI}}

Researchers say diets rich in Omega-3 fatty acids can help people with heart disease live longer, but why these oils are so beneficial remains unclear. A new study looks at how higher fish oil levels in the blood may protect the caps on chromosomes, which help measure biological aging

External Links

http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?CFRPart=184

References

  1. "Lipids Online Slides: hypertriglyceridemia, ICAM-1, fish oil, E-selectin".
  2. Terres W, Beil U, Reimann B, Tiede S, Bleifeld W (1991). "[Low-dose fish oil in primary hypertriglyceridemia. A randomized placebo-controlled study]". Zeitschrift für Kardiologie (in German). 80 (1): 20–4. PMID 2035283.
  3. "Fish oils in hypertriglyceridemia - Fish Oils Revisited Nutrition Research Newsletter - Find Articles".
  4. Durrington PN, Bhatnagar D, Mackness MI, Morgan J, Julier K, Khan MA; et al. (2001). "An omega-3 polyunsaturated fatty acid concentrate administered for one year decreased triglycerides in simvastatin treated patients with coronary heart disease and persisting hypertriglyceridaemia". Heart. 85 (5): 544–8. PMC 1729738. PMID 11303007.


Template:WikiDoc Sources